HUANG Jinghui, ZHAO Yan, YANG Zhihui, et al. Blood Concentration Monitoring of Digoxin in A Hospital and Its Influencing Factors. [J]. 22(8):976-979(2022)
DOI:
HUANG Jinghui, ZHAO Yan, YANG Zhihui, et al. Blood Concentration Monitoring of Digoxin in A Hospital and Its Influencing Factors. [J]. 22(8):976-979(2022) DOI: 10.14009/j.issn.1672-2124.2022.08.018.
Blood Concentration Monitoring of Digoxin in A Hospital and Its Influencing Factors
OBJECTIVE: To probe into the influencing factors of digoxin blood concentration(SDC) in the hospital. METHODS: Based on the system query method
the SDC of inpatients in the hospital from Jan. 2019 to Oct. 2021 were summarized. SDC
age
gender
creatinine clearance rate(CrCl)
potassium level and drug combination of inpatients with therapeutic drug monitoring during digoxin treatment were statistically analyzed by retrospective study. RESULTS: A total of 418 inpatients monitored for SDC were included
and the average SDC was(1.22±0.98)ng/mL; among them
171 patients(40.91%) had SDC within the normal range
200 patients(47.85%) had SDC <0.50 ng/mL
and 47 patients(11.24%) had SDC >1.75 ng/mL. Gender
age
CrCl(<30 mL/min) and combined application with macrolide antibiotics had significant effects on SDC(P<0.05). CONCLUSIONS: Only about 40% of patients using digoxin in this hospital had SDCs within the effective therapeutic window
and >45% had SDCs below the minimum effective therapeutic concentration
indicating that the clinical dose is conservative. When using digoxin
clinicians and clinical pharmacists should pay attention to patients’ age
gender
CrCl and combined application with macrolide antibiotics and potassium-removing diuretics
and timely adjust the dosage for patients with abnormal SDC monitoring results to improve the clinical treatment effect.
关键词
地高辛治疗药物监测年龄性别肌酐清除率联合用药
Keywords
DigoxinTherapeutic drug monitoringAgeGenderCreatinine clearanceDrug combination